Do Differences in Learning Performance Precede or Follow Initiation of Marijuana Use?
Journal
Journal of studies on alcohol and drugs
ISSN: 1938-4114
Titre abrégé: J Stud Alcohol Drugs
Pays: United States
ID NLM: 101295847
Informations de publication
Date de publication:
01 2019
01 2019
Historique:
entrez:
27
2
2019
pubmed:
27
2
2019
medline:
1
4
2020
Statut:
ppublish
Résumé
Studies examining cross-sectional associations between age at marijuana initiation and memory deficits yield mixed results. Because longitudinal data are sparse, controversy continues regarding whether these deficits reflect premorbid risk factors or sequelae of early marijuana initiation; here, we examine this question in a community sample followed since birth. Masked examiners administered four subtests of the Wide Range Assessment of Memory and Learning (WRAML/WRAML2) from childhood until young adulthood to 119 urban, predominantly African American participants. Multivariable generalized estimated equation models measured longitudinal trajectories of learning. Participants were grouped as never users (n = 26), later initiators (≥16 years old; n = 31), and earlier initiators of marijuana use (n = 62). Marijuana onset groups did not significantly differ on WRAML scaled scores or IQ in childhood, nor did they differ on WRAML scaled scores in adolescence. On most WRAML2 subtests, these groups did not significantly differ in young adulthood after taking into account sex and childhood IQ. However, on Story Memory, later initiators attained higher scaled scores in young adulthood, even after including additional covariates of anxiety, depression, postsecondary education, past-month marijuana use, and past-week high-risk drinking. They showed a significantly more positive trajectory than never users that was driven by within-group improvement after adolescence. Earlier initiators showed within-group decline in Story Memory after adolescence. Differences in learning following earlier initiation of marijuana use may not be solely attributable to premorbid deficits.
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Langues
eng
Sous-ensembles de citation
IM
Pagination
5-14Subventions
Organisme : NCRR NIH HHS
ID : M01 RR000533
Pays : United States
Organisme : NIDA NIH HHS
ID : R01 DA006532
Pays : United States
Organisme : NCRR NIH HHS
ID : UL1 RR025771
Pays : United States
Références
J Clin Exp Neuropsychol. 2017 Jun;39(5):502-512
pubmed: 27753292
Psychol Med. 2004 Oct;34(7):1239-50
pubmed: 15697050
Proc Natl Acad Sci U S A. 2016 Feb 2;113(5):E500-8
pubmed: 26787878
Br J Psychiatry. 2011 Jun;198(6):442-7
pubmed: 21628706
Psychopharmacology (Berl). 2014 Apr;231(8):1455-65
pubmed: 24190588
J Int Neuropsychol Soc. 2014 Sep;20(8):784-95
pubmed: 25241623
Neurotoxicol Teratol. 2011 May-Jun;33(3):379-92
pubmed: 21371553
Exp Clin Psychopharmacol. 2004 Feb;12(1):47-56
pubmed: 14769099
Proc Natl Acad Sci U S A. 2012 Oct 2;109(40):E2657-64
pubmed: 22927402
Neuropsychology. 2016 May;30(4):405-15
pubmed: 26986749
Neurosci Biobehav Rev. 2017 Jan;72:68-86
pubmed: 27851897
Addiction. 2011 Dec;106(12):2195-203
pubmed: 21749524
Arch Clin Neuropsychol. 2002 Jan;17(1):57-67
pubmed: 14589753
Neurotoxicol Teratol. 2005 Mar-Apr;27(2):231-9
pubmed: 15734274
Psychol Addict Behav. 2017 Jun;31(4):423-434
pubmed: 28414475
Neuropsychology. 2014 Sep;28(5):782-790
pubmed: 24749728
Psychopharmacology (Berl). 2014 Apr;231(8):1467-77
pubmed: 24619597
Biol Psychiatry. 2016 Apr 1;79(7):557-67
pubmed: 26858214
J Stud Alcohol Drugs. 2016 Mar;77(2):298-308
pubmed: 26997188
J Clin Exp Neuropsychol. 2015;37(4):389-401
pubmed: 25832823
Trauma Violence Abuse. 2016 Dec;17(5):454-467
pubmed: 25964275
Addiction. 2006 Sep;101(9):1313-22
pubmed: 16911731
Neurotoxicol Teratol. 2001 Jan-Feb;23(1):1-11
pubmed: 11274871
Biol Psychiatry. 2012 Apr 15;71(8):684-92
pubmed: 22129756
Addict Behav. 2014 May;39(5):994-9
pubmed: 24556155
Neuropsychol Rev. 2013 Jun;23(2):117-37
pubmed: 23129391
J Consult Clin Psychol. 2000 Feb;68(1):134-44
pubmed: 10710848
Am J Drug Alcohol Abuse. 2017 Sep;43(5):567-575
pubmed: 27929672
Mol Psychiatry. 2017 Jan;22(1):68-75
pubmed: 27001613
Dev Cogn Neurosci. 2015 Dec;16:84-92
pubmed: 25936584
Aggress Behav. 2016 May-Jun;42(3):209-21
pubmed: 26660077
Neuropsychology. 2015 Nov;29(6):829-843
pubmed: 25938918
Addict Behav. 2010 Nov;35(11):970-6
pubmed: 20621421
Psychopharmacology (Berl). 2013 Mar;226(2):307-19
pubmed: 23138434
Proc Natl Acad Sci U S A. 2013 Mar 12;110(11):E979
pubmed: 23460701
Prog Neuropsychopharmacol Biol Psychiatry. 2010 Aug 16;34(6):871-6
pubmed: 20398718
Schizophr Bull. 2014 Mar;40(2):287-99
pubmed: 24342821
Psychol Addict Behav. 2012 Sep;26(3):496-506
pubmed: 22103843
Drug Alcohol Depend. 2013 Dec 1;133(2):607-14
pubmed: 23992650
Curr Addict Rep. 2014 Jun 1;1(2):144-156
pubmed: 25013751
Neurotoxicol Teratol. 2011 Jan-Feb;33(1):100-9
pubmed: 20600847
J Int Neuropsychol Soc. 2007 Sep;13(5):807-20
pubmed: 17697412
Hippocampus. 2015 Sep;25(9):1042-51
pubmed: 25760303
Drug Alcohol Depend. 2014 Sep 1;142:181-90
pubmed: 24999059
Drug Alcohol Depend. 2003 Apr 1;69(3):303-10
pubmed: 12633916
Early Interv Psychiatry. 2010 Aug;4(3):227-33
pubmed: 20712728
Neurotoxicol Teratol. 1999 Mar-Apr;21(2):109-18
pubmed: 10192271